ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
121.802,06
-0,19%
S&P 500
5.291,34
0,15%
US Dollar vs BRL
5,2902
0,02%
Bitcoin
70.958,10
0,47%
Brent Oil
77,605
0,64%
Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. GeoVax Labs Inc (GOVXW)

  7. GeoVax Labs Inc (GOVXW) Notícias

GOVXW GeoVax Labs Inc

0,0375
0,00 (0,00%)
Pré-mercado
Última atualização: 05:00:00
Atrasado em 15 minutos
Nome da Ação Código da Ação Bolsa de Valores Tipo de Ativo
GeoVax Labs Inc GOVXW NASDAQ Equity Warrant
  Variação do Dia (p) Variação do Dia % Último Preço Hora
Upgrade Icon
0,00 0,00% 0,0375 05:00:00
Preço de Abertura Preço Mínimo Preço Máximo Fech. Hoje Fech. Anterior
0,0375
mais cotações »

Notícias Recentes

Data Hora Fonte Título
04/04/202413:30GLOBEGeoVax Presents Data on GEO-CM04S1, a Next Generation..
28/03/202410:00GLOBEGeoVax to Present Data on GEO-CM04S1, a Next Generation..
12/03/202410:00GLOBEGeoVax to Present at the 36th Annual Roth Conference
06/03/202411:00GLOBEGeoVax Achieves Milestone in Transition to Commercially..
29/02/202418:00GLOBEGeoVax Reports 2023 Year-End Financial Results and Provides..
22/02/202411:00GLOBEGeoVax to Report 2023 Financial Results and Provide..
19/02/202411:00GLOBEGeoVax to Present at the 2024 BIO CEO & Investor Conference
13/02/202411:00GLOBEGeoVax Announces Multiple Patent Issuances and Allowances
06/02/202411:00GLOBEGeoVax Reports Positive Interim Data From Phase 2 Clinical..
29/01/202411:00GLOBEGeoVax Announces 1-for-15 Reverse Stock Split to Regain..
08/01/202411:00GLOBEGeoVax Appoints Dr. Marc Pipas as Executive Medical..
04/01/202411:00GLOBEGeoVax Announces Gedeptin® Patient Enrollment Closure for..
03/01/202411:00GLOBEGeoVax Announces Issuance of Malaria Vaccine Patent
27/12/202311:00GLOBEGeoVax to Present at Biotech Showcase During J.P. Morgan..
19/12/202311:00GLOBEGeoVax Expands Rights Under NIH COVID-19 License to Include..
30/11/202318:30GLOBEGeoVax Hemorrhagic Fever Vaccine Data Presented at World..
29/11/202311:00GLOBEGeoVax to Participate in Upcoming December Investor Events
28/11/202311:00GLOBEGeoVax COVID-19 Vaccine Clinical Data Presented at World..
14/11/202311:00GLOBEProgress on GeoVax’s Universal Coronavirus Vaccine..
08/11/202318:00GLOBEGeoVax Reports Third Quarter 2023 Financial Results and..
31/10/202310:00GLOBEGeoVax to Report Third Quarter 2023 Financial Results and..
30/10/202310:00GLOBEGeoVax Commences Site Expansion for Phase 2 Trial of..
25/10/202310:00GLOBEGeoVax to Participate in Upcoming November Investor and..
24/10/202310:00GLOBEGeoVax Update: Clinical and Operational Progress Toward..
09/10/202310:00GLOBEGeoVax Receives Notice of Allowance for Marburg Vaccine..
05/10/202310:00GLOBEGeoVax Receives Notice of Allowance for HIV Vaccine Patent
27/09/202310:00GLOBEGeoVax to Participate in Upcoming October Investor and..
26/09/202310:00GLOBEGeoVax Secures Multi-Product License for ProBioGen's..
20/09/202310:00GLOBEGeoVax Next-Generation COVID-19 Vaccine Data Presented at..
19/09/202310:00GLOBEGeoVax Next-Generation COVID-19 Vaccine Demonstrates Potent..
12/09/202310:00GLOBEGeoVax Presents Corporate Update at the H.C. Wainwright 25th..
11/09/202310:00GLOBEGeoVax Completes Enrollment of Phase 2 Trial for..
31/08/202310:00GLOBEGeoVax to Present at the H.C. Wainwright 25th Annual Global..
28/08/202310:00GLOBEGeoVax Receives Notice of Allowance for Malaria Vaccine..
10/08/202310:00GLOBEGeoVax Announces First Patients Vaccinated in Phase 2..
09/08/202317:00GLOBEGeoVax Reports 2023 Second Quarter Financial Results and..
26/07/202310:00GLOBEGeoVax to Report Second Quarter 2023 Financial Results and..
24/07/202310:00GLOBEGeoVax Announces Issuance of Ebola Vaccine Patent
20/07/202310:00GLOBEGeoVax Announces Initiation of Phase 2 Clinical Trial of..
10/07/202310:00GLOBEGeoVax Presents Gedeptin® Clinical Data at the AACR-AHNS..
28/06/202310:00GLOBEGeoVax Announces Gedeptin® Presentation at the AACR-AHNS..
27/06/202311:15GLOBEGeoVax Universal Coronavirus Vaccine Design & Development..

Seu Histórico Recente

NASDAQ
GOVXW
GeoVax Labs
NASDAQ
NEWTL
NewtekOne
TSX
EMV.B
CI Emerging Markets Divi...
LSE
0VR2
Lion E Mobility
ASX
TMSO
Tennant Minerals
TSXV
PBX
PowerBand Solutions
BOV
AZUL4M
AZUL PN
TSXV
STER
Steer Technologies
BIT
P1VF34
NLBNPIT1VF34 20240621 10
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados